IP Library Assignment 058738/0271
Patent Assignment
Reel/Frame 058738/0271

Change of Name

Recorded: 2022-01-24 Pages: 5
Assignor
VERNALIS DEVELOPMENT LIMITED
Executed: 2020-12-03
Assignee
LIGAND UK DEVELOPMENT LIMITED
GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, ENGLAND, CB21 6GB, UNITED KINGDOM
Covered Properties (34)
Triazolo[4,5-D]Pyrimidine Derivatives and Their Use as Purinergic Receptor Antagonists
Patent: 7,141,575 →
Application: 10/250,942 →
Publication: US 2004/0097526
Isoxazole Compounds as Inhibitors of Heat Shock Proteins
Patent: 7,705,027 →
Application: 10/544,443 →
Publication: US 2006/0241106
Triazolo [4,5-D] Pyrimidine Derivatives and Their Use as Purinergic Receptor Antagonists
Patent: 7,405,219 →
Application: 11/507,625 →
Publication: US 2007/0049607
2-Amino-7,8-Dihydro-6H-Pyrido[4,3-D]Pyrimidin-5-Ones
Patent: 7,671,059 →
Application: 11/541,462 →
Publication: US 2007/0123546
Triazolo[4,5-D] Pyramidine Derivatives and Their Use as Purinergic Receptor Antagonists
Patent: 7,589,097 →
Application: 12/003,110 →
Publication: US 2008/0234296
Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-Isopropyl-Phenyl)-4-(4-Morpholin-4-Ylmethyl-Phenyl)-Isoxazole-3-Carboxylic Acid Ethylamide and Formulations Comprising These Forms
Patent: 8,163,747 →
Application: 12/529,090 →
Publication: US 2010/0093732
Thienopyrimidine Compounds
Patent: 9,120,807 →
Application: 12/678,378 →
Publication: US 2011/0118284
Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
Patent: 8,507,480 →
Application: 12/708,686 →
Publication: US 2010/0179138
Azetidine Derivatives as Faah Inhibitors
Patent: 8,450,346 →
Application: 12/920,181 →
Publication: US 2012/0028953
Triazolo[4,5-D]Pyramidine Derivatives and Their Use as Purine Receptor Antagonists
Patent: 8,450,328 →
Application: 12/997,721 →
Publication: US 2011/0172252
Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-Iso-Propyl-Phenyl)-4-(4-Morpholin-4-Ylmethyl-Phenyl)-Isoxazole-3-Carboxylic Acid Ethylamide and Formulations Comprising These Forms
Patent: 8,487,095 →
Application: 13/415,268 →
Publication: US 2012/0172592
Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
Patent: 8,450,310 →
Application: 13/525,409 →
Publication: US 2012/0252797
Azetidine Derivatives
Patent: 9,006,269 →
Application: 13/866,059 →
Publication: US 2013/0331371
Triazolo[4, 5-D] Pyramidine Derivatives and Their Use as Purine Receptor Antagonists
Patent: 8,987,279 →
Application: 13/889,921 →
Publication: US 2013/0245044
Isoxazole Compounds as Inhibitors of Heat Shock Proteins
Patent: 9,718,793 →
Application: 13/929,098 →
Publication: US 2013/0289026
1H-Pyrrolo[2,3-B] Pyridine Derivatives and Their Use as Kinase Inhibitors
Application: 14/375,353 →
Publication: US 2015/0011533
Triazolo[4,5-D] Pyramidine Derivatives and Their Use as Purine Receptor Antagonists
Patent: 9,376,443 →
Application: 14/618,829 →
Publication: US 2015/0291602
Azetidine Derivatives
Patent: 9,475,800 →
Application: 14/641,783 →
Publication: US 2015/0183769
Thienopyrimidine Compounds
Patent: 9,610,290 →
Application: 14/803,214 →
Publication: US 2015/0342953
Triazolo[4,5-D] Pyramidine Derivatives and Their Use as Purine Receptor Antagonists
Patent: 9,765,080 →
Application: 15/172,126 →
Publication: US 2017/0088552
Azetidine Derivatives
Application: 15/278,386 →
Publication: US 2017/0196864
Thienopyrimidine Compounds
Patent: 9,920,066 →
Application: 15/436,988 →
Publication: US 2017/0291907
Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
Application: 15/631,059 →
Publication: US 2017/0326152
Triazolo[4,5-D] Pyramidine Derivatives and Their Use as Purine Receptor Antagonists
Application: 15/682,346 →
Publication: US 2017/0342081
Thienopyrimidine Compounds
Application: 15/891,618 →
Publication: US 2018/0162872
1H-Pyrrolo [2,3-B] Pyridine Derivatives and Their Use as Kinase Inhibitors
Application: 16/009,439 →
Publication: US 2018/0362526
Triazolo[4,5-D] Pyramidine Derivatives and Their Use as Purine Receptor Antagonists
Application: 16/132,411 →
Publication: US 2019/0031668
Azetidine Derivatives
Application: 16/506,225 →
Publication: US 2020/0000805
Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
Application: 16/528,278 →
Publication: US 2019/0358241
Triazolo[4,5-D] Pyramidine Derivatives and Their Use as Purine Receptor Antagonists
Application: 16/700,160 →
Publication: US 2020/0172547
Thienopyrimidine Compounds
Application: 16/726,308 →
Publication: US 2020/0140455
Triazolo[4,5-D] Pyramidine Derivatives and Their Use as Purine Receptor Antagonists
Application: 17/088,325 →
Publication: US 2021/0115054
1H-Pyrrolo[2,3-B] Pyridine Derivatives and Their Use as Kinase Inhibitors
Application: 17/107,176 →
Publication: US 2021/0206762
Azetidine Derivatives
Application: 17/148,785 →
Publication: US 2021/0267974
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 8, 2003
From: GILLESPIE, ROGER JOHN; LERPINIERE, JOANNE; GAUR, SUNEEL; BAMFORD, SAMANTHA JAYNE
To: VERNALIS RESEARCH LIMITED
Reel/Frame 014572/0667 →
Assignment of Assignor's Interest Apr 21, 2006
From: DRYSDALE, MARTIN JAMES; DYMOCK, BRIAN WILLIAM; FINCH, HARRY; WEBB, PAUL
To: VERNALIS (CAMBRIDGE) LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED; INSTITUTE OF CANCER RESEARCH, THE
Reel/Frame 017809/0676 →
Assignment of Assignor's Interest Mar 1, 2007
From: MACHAJEWSKI, TIMOTHY D.; SHAFER, CYNTHIA M.; MCBRIDE, CHRISTOPHER; ANTONIOS-MCCREA, WILLIAM R.
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 019016/0669 →
Assignment of Assignor's Interest Mar 1, 2007
From: MACHAJEWSKI, TIMOTHY D.; SHAFER, CYNTHIA M.; MCBRIDE, CHRISTOPHER; ANTONIOS-MCCREA, WILLIAM R.
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 018982/0045 →
Assignment of Assignor's Interest Mar 1, 2007
From: MACHAJEWSKI, TIMOTHY D.; SHAFER, CYNTHIA M.; MCBRIDE, CHRISTOPHER; ANTONIOS-MCCREA, WILLIAM R.
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 018973/0069 →
Assignment of Assignor's Interest Mar 1, 2007
From: MACHAJEWSKI, TIMOTHY D.; SHAFER, CYNTHIA M.; MCBRIDE, CHRISTOPHER; ANTONIOS-MCCREA, WILLIAM R.
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 018973/0032 →
Assignment of Assignor's Interest Mar 1, 2007
From: MACHAJEWSKI, TIMOTHY D.; SHAFER, CYNTHIA M.; MCBRIDE, CHRISTOPHER; ANTONIOS-MCCREA, WILLIAM R.
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 018965/0454 →
Assignment of Assignor's Interest May 9, 2008
From: POON, DANIEL; BARSANTI, PAUL A; LIN, XIAODONG; COSTALES, ABRAN
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 020929/0969 →
Assignment of Assignor's Interest May 15, 2008
From: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
To: NOVARTIS AG
Reel/Frame 020952/0946 →
Assignment of Assignor's Interest Jun 21, 2010
From: JORDAN, ALLAN; BEDFORD, SIMON; BURKHARD, KLENKE; YULE, IAN
To: VERNALIS (R&D) LTD.
Reel/Frame 024564/0535 →
Assignment of Assignor's Interest Mar 31, 2011
From: BAMFORD, SAMANTHA JANE; GILLESPIE, ROGER JOHN; TODD, RICHARD SIMON
To: VERNALIS (R&D) LIMITED
Reel/Frame 026106/0129 →
Assignment of Assignor's Interest Sep 1, 2011
From: ROUGHLEY, STEPHEN; WALLS, STEVEN; PARSONS, RACHEL; BROUGH, PAUL
To: VERNALIS (R&D) LTD.
Reel/Frame 026841/0599 →
Assignment of Assignor's Interest Feb 13, 2012
From: DRYSDALE, MARTIN JAMES; DYMOCK, BRIAN WILLIAM
To: VERNALIS (R&D) LTD.
Reel/Frame 027694/0615 →
Assignment of Assignor's Interest Feb 13, 2012
From: KRELL, CHRSTIOPH; MUTZ, MICHAEL; PETERSEN, HOLGER; ZHENG, WEIJIA
To: NOVARTIS AG
Reel/Frame 027694/0510 →
Assignment of Assignor's Interest Dec 12, 2012
From: VERNALIS (CAMBRIDGE) LIMITED
To: VERNALIS (R&D) LIMITED
Reel/Frame 029450/0945 →
Assignment of Assignor's Interest May 10, 2013
From: ROUGHLEY, STEPHEN; WALLS, STEVEN; PARSONS, RACHEL; BROUGH, PAUL
To: VERNALIS (R&D) LTD.
Reel/Frame 030391/0258 →
Assignment of Assignor's Interest Jul 3, 2013
From: VERNALIS (CAMBRIDGE) LIMITED
To: VERNALIS (R&D) LIMITED
Reel/Frame 030732/0404 →
Assignment of Assignor's Interest Jul 3, 2013
From: DRYSDALE, MARTIN JAMES; FINCH, HARRY; WEBB, PAUL; MCDONALD, EDWARD
To: VERNALIS (CAMBRIDGE) LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED; THE INSTITUTE OF CANCER RESEARCH
Reel/Frame 030732/0384 →
Assignment of Assignor's Interest Jan 13, 2014
From: VERNALIS RESEARCH LIMITED
To: VERNALIS (R&D) LIMITED
Reel/Frame 031949/0742 →
Assignment of Assignor's Interest Oct 6, 2014
From: STOKES, STEPHEN; GRAHAM, CHRISTOPHER JOHN; RAY, STUART CHRISTOPHER; STEFANIAK, EMMA JAYNE
To: VERNALIS (R&D) LIMITED
Reel/Frame 033889/0711 →
Assignment of Assignor's Interest Jan 24, 2022
From: VERNALIS (R&D) LIMITED
To: VERNALIS DEVELOPMENT LIMITED
Reel/Frame 058822/0570 →
Assignment of Assignor's Interest Jan 26, 2022
From: NOVARTIS AG
To: VERNALIS (R&D) LIMITED
Reel/Frame 058771/0965 →